MSME (Udyam registered) Ministry of MSME
- Category
- Micro (2024-25)
- Udyam number
- UDYAM-HR-05-0016036
Ekshi Pharmaceuticals Private Limited
Ekshi Pharmaceuticals Private Limited - business services in Gurugram, Haryana, India. FY 2026 financials & compliance.
Revenue · FY 2025
₹13.8 Lakh
▼ 54% YoY
Net profit · FY 2025
₹1,253
Net margin 0.1%
EBITDA · FY 2025
₹33,761
EBITDA margin 2.4%
Authorised capital
₹1 Lakh
Registered with MCA
Paid-up capital
₹1 Lakh
Issued & subscribed
Company age
9 yrs
Est. 2017
Directors on board
2
As per MCA filings
Active GSTINs
1
GST registered
About Ekshi Pharmaceuticals Private Limited
Data last updated:
Ekshi Pharmaceuticals Private Limited is a private limited company based in Gurugram, Haryana, India. It operates in the service-based operations segment of the business services sector. It was incorporated on 10 November 2017 and has been in existence for over 9 years.
The company is registered with the Registrar of Companies (ROC), Haryana, under CIN U74999HR2017PTC071432. Its GSTIN is 08AAECE8435G1ZJ (Rajasthan).
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Sunil Dhariwal and Neelam Dhariwal.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 176/22 Gandhi Nagar, Gurugram, Haryana, India – 122001.
As per the financials filed for FY 2025, the company reported a revenue of ₹13.8 Lakh, a decline of 54% compared to the previous year. For the same year it recorded a net profit of ₹1,253 (net margin 0.1%) and EBITDA of ₹33,761 (EBITDA margin 2.4%). Revenue has grown at a compounded annual rate (CAGR) of 19% over three years and 33% over five years.
Ekshi Pharmaceuticals Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-HR-05-0016036). The current compliance status is marked as compliant by the Registrar of Companies.
Company details
CIN U74999HR2017PTC071432
Registration Number 071432
Incorporation Date 10 November 2017
ROC Haryana
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant
MSME Classification Micro
Udyam Registration UDYAM-HR-05-0016036
Key People
Sunil Dhariwal Director Neelam Dhariwal Director Recognitions & Rankings of Ekshi Pharmaceuticals
Contact details
Ekshi Pharmaceuticals Private Limited's registered office is in Gurugram, Haryana. Its e-mail address is in the company report.
- Email
- Registered Address176/22 Gandhi Nagar, Gurugram, Haryana, India – 122001
- IndustryBusiness Services, Other Services, Miscellaneous Business Activities
To see the full contact details of Ekshi Pharmaceuticals Private Limited, buy the company report.
Comprehensive company report
Ekshi Pharmaceuticals Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Business activity
The main business activity of Ekshi Pharmaceuticals is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Ekshi Pharmaceuticals Private Limited, buy the company report.
Financials of Ekshi Pharmaceuticals Private Limited
FY 2025 filings availableEkshi Pharmaceuticals Private Limited reported revenue of ₹13.8 Lakh (down 54% YoY) for FY 2025.
Revenue · FY 2025
₹13.8 Lakh ▼ 54%
Net profit · FY 2025
₹1,253 margin 0.1%
EBITDA · FY 2025
₹33,761 margin 2.4%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▼ 54%
3 years · compounded
▼ 19%
5 years · compounded
▲ 33%
EBITDA CAGR growth
1 year
▼ 54%
3 years · compounded
▼ 7%
5 years · compounded
▲ 30%
Revenue fell 54% in the latest year, but over five years it has grown at a compounded annual rate (CAGR) of 33%. EBITDA fell 54% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹33,761 | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹1,253 | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 2.4% | ||||
| Net Profit Margin | 0.1% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Ekshi Pharmaceuticals Private Limited, buy the company report.
Board of directors of Ekshi Pharmaceuticals Private Limited
Ekshi Pharmaceuticals has 2 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Sunil Dhariwal | Director | 10 Nov 2017 | 8 Years 11 Months | Current |
| Neelam Dhariwal | Director | 29 Apr 2019 | 7 Years 6 Months | Current |
Legal cases
No court or tribunal cases involving Ekshi Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Ekshi Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Ekshi Pharmaceuticals has 1 GST registration: 1 active.
Total GSTINs
1
Active
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 08AAECE8435G1ZJ | Rajasthan | Active | 29 May 2019 |
To see the full GST registrations and return filing status of Ekshi Pharmaceuticals Private Limited, buy the company report.
Recent activity
Ekshi Pharmaceuticals Private Limited has 3 board changes on record since 2017: 2 appointments and 1 cessation. The latest: Neelam Dhariwal was appointed as Director on 29 Apr 2019.
AGM
Ekshi Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Ekshi Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Haryana.
Appointed
Neelam Dhariwal was appointed as Director.
Ceased
Praveen ceased to be Director.
Appointed
Sunil Dhariwal was appointed as Director.
Incorporation
10 Nov 2017
Ekshi Pharmaceuticals Private Limited was registered on 10 Nov 2017 with Roc Haryana & aged 8 years 11 months as per MCA records.
Frequently asked questions
Ekshi Pharmaceuticals is an active private limited company based in Gurugram, Haryana, India. The company works in other services, within the business services industry. It was incorporated on 10 November 2017 (9+ years old) and is registered under CIN U74999HR2017PTC071432.
Ekshi Pharmaceuticals has 2 current directors:
- Sunil Dhariwal - Director
- Neelam Dhariwal - Director
The latest financial statements of Ekshi Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2018 are in the company report.
The GSTIN of Ekshi Pharmaceuticals is 08AAECE8435G1ZJ, registered in Rajasthan.
The CIN (Corporate Identification Number) of Ekshi Pharmaceuticals is U74999HR2017PTC071432. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Ekshi Pharmaceuticals was incorporated on 10 November 2017, making it 9+ years old. It is registered with the Registrar of Companies, Haryana.
Neelam Dhariwal was appointed as Director on 29 Apr 2019. Praveen ceased to be Director on 29 Apr 2019. Sunil Dhariwal was appointed as Director on 10 Nov 2017.
Yes, Ekshi Pharmaceuticals is registered as a micro enterprise under Udyam registration (number: UDYAM-HR-05-0016036).
The registered office of Ekshi Pharmaceuticals is at 17622 Gandhi Nagar, Gurugram, Haryana, India – 122001.
Ekshi Pharmaceuticals operates in the business services industry, in the other services segment.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
Swiggy Limited Listed company · 92 pages
BharatPe (Resilient Innovations Pvt Ltd) Unlisted company · 78 pages